Approx 1 in 13 People in the US PTSD

PTSD; Phase II Clinical Trial; Lithium Salicylate with Proline; LiProSal; LisPro; AL001; Massachusetts General Hospital;

Approximately 1 in 13 people in the US will develop PTSD in their lifetime. All rights reserved; proprietary content owned by Alzamend Neuro, Inc.

Format

PNG

Source

Alzamend Neuro, Inc.

Downloads